Coronado Biosciences to Present at the 2012 JMP Securities Healthcare Conference
Published: Jul 03, 2012
BURLINGTON, Mass., July 3, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, today announced that Dr. Bobby W. Sandage, Jr., Coronado's President and CEO, will present at the 2012 JMP Securities Healthcare Conference on Thursday, July 12, 2012 at 1:00 pm ET. The conference will be held July 12-13, 2012 at The Peninsula Hotel in New York. A webcast of the presentation will be available at www.coronadobiosciences.com on the Events & Webcasts page.